United Therapeutics' GAAP net income for 3 months of 2021 was $28.3 million, down 4.9 times from $137.7 million in the previous year. Revenue increased 6.4% to $379.1 million from $356.3 million a year earlier.
United Therapeutics' GAAP net income for 3 months of 2021 was $28.3 million, down 4.9 times from $137.7 million in the previous year. Revenue increased 6.4% to $379.1 million from $356.3 million a year earlier. 
ir.unither.com
English (US) 